DE602004005624D1 - Antigene Fragmente vom gp21 Hüllprotein des humanen T-lymphotropen Virus HTLV - Google Patents

Antigene Fragmente vom gp21 Hüllprotein des humanen T-lymphotropen Virus HTLV

Info

Publication number
DE602004005624D1
DE602004005624D1 DE602004005624T DE602004005624T DE602004005624D1 DE 602004005624 D1 DE602004005624 D1 DE 602004005624D1 DE 602004005624 T DE602004005624 T DE 602004005624T DE 602004005624 T DE602004005624 T DE 602004005624T DE 602004005624 D1 DE602004005624 D1 DE 602004005624D1
Authority
DE
Germany
Prior art keywords
human
envelope protein
antigenic fragments
lymphotropic virus
virus htlv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004005624T
Other languages
English (en)
Other versions
DE602004005624T2 (de
Inventor
Hsin-Yu Lin
Ching-Long Hwong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Development Center for Biotechnology
Original Assignee
Development Center for Biotechnology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/423,156 external-priority patent/US7033751B2/en
Application filed by Development Center for Biotechnology filed Critical Development Center for Biotechnology
Publication of DE602004005624D1 publication Critical patent/DE602004005624D1/de
Application granted granted Critical
Publication of DE602004005624T2 publication Critical patent/DE602004005624T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE602004005624T 2003-04-25 2004-01-08 Antigene Fragmente vom gp21 Hüllprotein des humanen T-lymphotropen Virus HTLV Expired - Lifetime DE602004005624T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/423,156 US7033751B2 (en) 2002-12-12 2003-04-25 Antigenic fragment of human T-lymphotropic virus
US423156 2003-04-25

Publications (2)

Publication Number Publication Date
DE602004005624D1 true DE602004005624D1 (de) 2007-05-16
DE602004005624T2 DE602004005624T2 (de) 2007-12-27

Family

ID=33029747

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004005624T Expired - Lifetime DE602004005624T2 (de) 2003-04-25 2004-01-08 Antigene Fragmente vom gp21 Hüllprotein des humanen T-lymphotropen Virus HTLV

Country Status (2)

Country Link
EP (1) EP1477495B1 (de)
DE (1) DE602004005624T2 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0424748B1 (de) * 1989-10-23 1995-05-10 F. Hoffmann-La Roche Ag Synthetische HTLV-I Hüll-Peptide
US6406841B1 (en) * 1993-07-01 2002-06-18 Abbott Laboratories Methods for the detection of HTLV-II antibodies employing novel HTLV-II NRA envelope peptides
US5643174A (en) * 1993-08-18 1997-07-01 Sumitomo Bakelite Company Limited Endoscopic guide tube with embedded coil spring
JP2001510553A (ja) * 1995-06-05 2001-07-31 アボツト・ラボラトリーズ 組換え蛋白質を用いたｈｔｌｖ抗体の検出法

Also Published As

Publication number Publication date
DE602004005624T2 (de) 2007-12-27
EP1477495B1 (de) 2007-04-04
EP1477495A1 (de) 2004-11-17

Similar Documents

Publication Publication Date Title
EA202192570A1 (ru) Иммуногенные композиции и вакцины, содержащие пептиды и белки вируса африканской чумы свиней, и их применение
IS7133A (is) Afleiða beta-amyloid - T-frumu-mótefnavísisbóluefni
CY2016044I1 (el) Σταθερο φαρμακευτικο σκευασμα σε υγρη μορφη αντισωματων igg
EA200801798A1 (ru) Виросомоподобные везикулы, содержащие антигены, производные от gp41
CR8292A (es) Solvato acetonico del dimetoxi docetaxel y su procedimiento de preparacion
DE602005027258D1 (de) Humane monoklonale antikörper gegen hendra- und nipah-viren
DK3626819T3 (da) Transgen mus, som producerer hybrid-antistoffer indeholdende humane variable områder og konstante områder fra mus
NO20041917L (no) Spesifikke midler som binder humant angiopoietin-2
CY2013025I1 (el) Ετερολογος εκφραση των πρωτεϊνων της neisseria
EP1490094A4 (de) Antikörper-fusionsproteine: wirksame adjuvantien bei der proteinvakzination
NL1026829A1 (nl) Gemodificeerde humane IGF-1R-antilichamen.
EP1599228A4 (de) Modifizierte antikörper gegen prostata-spezifisches membranantigen und ihre verwendungen
NO20034410D0 (no) Vaksinesammensetning
UA85536C2 (en) Viral antigens
WO2002074795A3 (en) Oligomeric complexes of chimeric proteins with enhanced immunogenic potential
DK1292328T3 (da) Kimære humant papillomvirus- (HPV) - molekyler og deres anvendelse
AU2003246373A8 (en) Recombinant measles viruses expressing epitopes of antigens of rna viruses - use for the preparation of vaccine compositions
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
NO20041802L (no) Antistoffer mot human vevsfaktor
DE60210864D1 (de) Modifiziertes fluoreszentes Protein
EP1557462A3 (de) Transplant-Akzeptanz induzierende Zellen monocytären ursprungs, sowie deren Herstellung und Verwendung
IL200747A0 (en) Subunits of the enteritis hemorrhagic virus fiber protein and uses thereof as vaccines
ITWX20020001A1 (it) Perfezionamenti in e relativi al lancio dei missili.
DE60232862D1 (de) Rekombinantes pockenvirus für chimäre proteine des menschlichen immunschwächevirus
DE602004030605D1 (de) Herstellung von titanoxid

Legal Events

Date Code Title Description
8364 No opposition during term of opposition